VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
THG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
THGThe Hanover Insurance Group, Inc.
$218.46$7.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTHGQuarterly Financials

The Hanover Insurance Group, Inc. (THG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

The Hanover Insurance Group, Inc. (THG) quarterly income statement — complete revenue, gross profit & net income history

THG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.7B1.67B1.66B1.65B1.6B1.58B1.56B1.54B1.54B1.53B1.52B1.5B1.44B1.48B1.37B1.29B1.33B1.37B1.27B1.31B
Revenue Growth %6.62%5.93%6.21%7.53%3.49%3.24%2.95%2.05%6.8%3.39%11%16.36%8.49%7.57%7.17%-1.14%3.79%5.99%2.51%6.82%
Medical Costs & Claims957.6M889.7M1.25B1.28B1.27B1.17B1.26B1.31B1.23B1.21B1.36B1.43B1.31B1.33B1.22B1.11B1.05B1.02B1.09B989.3M
Medical Cost Ratio %56.28%53.21%75.5%77.3%79.54%74.26%80.82%85.4%80.04%79.39%89.55%95.23%90.48%90.26%89.05%86.22%78.94%74.05%85.34%75.65%
Gross Profit743.8M782.2M406.2M374.7M326.5M406.3M299.5M224.2M307.7M315.1M158.5M71.8M137.5M144M149.6M178.1M280.3M356.7M186.9M318.5M
Gross Margin %43.72%46.79%24.5%22.7%20.46%25.74%19.18%14.6%19.96%20.61%10.45%4.77%9.52%9.74%10.95%13.78%21.06%25.95%14.66%24.35%
Gross Profit Growth %127.81%92.52%35.63%67.13%6.11%28.94%88.96%212.26%123.78%118.82%5.95%-59.69%-50.95%-59.63%-19.96%-44.08%7.6%-1.63%-36.92%15.82%
Operating Expenses506.7M524.4M179.1M175.9M166.4M194.8M169.8M172.9M162.4M164.9M159.4M162.5M155M158.7M149.1M149.9M150.3M151.9M144.4M158.6M
OpEx / Revenue %29.78%31.37%10.8%10.65%10.43%12.34%10.88%11.26%10.53%10.79%10.51%10.8%10.74%10.73%10.91%11.59%11.29%11.05%11.33%12.13%
Depreciation & Amortization00-1.2M-1M-1.1M-600K500K800K800K800K1.5M1.8M2.2M2.9M3.8M2.9M3.3M4.4M4.3M4.4M
Combined Ratio %86.06%84.58%86.3%87.96%89.97%86.6%91.69%96.66%90.58%90.18%100.06%106.03%101.21%100.99%99.96%97.82%90.23%85.1%96.67%87.77%
Operating Income237.1M257.8M227.1M198.8M160.1M211.5M129.7M51.3M145.3M150.2M-900K-90.7M-17.5M-14.7M500K28.2M130M204.8M42.5M159.9M
Operating Margin %13.94%15.42%13.7%12.04%10.03%13.4%8.31%3.34%9.42%9.82%-0.06%-6.03%-1.21%-0.99%0.04%2.18%9.77%14.9%3.33%12.23%
Operating Income Growth %48.09%21.89%75.1%287.52%10.19%40.81%14511.11%156.56%930.29%1121.77%-280%-421.63%-113.46%-107.18%-98.82%-82.36%13.94%-1.06%-71.4%11.74%
EBITDA237.1M272.3M225.9M197.8M159M210.9M130.2M52.1M146.1M151M600K-88.9M-15.3M-11.8M4.3M31.1M133.3M209.2M46.8M164.3M
EBITDA Margin %13.94%16.29%13.62%11.98%9.96%13.36%8.34%3.39%9.48%9.88%0.04%-5.91%-1.06%-0.8%0.31%2.41%10.02%15.22%3.67%12.56%
Interest Expense10.8M14.5M11.6M8.6M8.5M8.5M8.5M8.6M8.5M8.5M8.5M8.6M8.5M8.6M8.5M8.5M8.5M8.5M8.5M8.5M
Non-Operating Income0-14.5M-11.6M-8.6M-8.5M-8.5M-8.5M-8.6M-8.5M-8.5M-8.5M-8.6M-8.5M-8.6M-8.5M-8.5M-8.5M-8.5M-8.5M-8.5M
Pretax Income237.1M257.8M227.1M198.8M160.1M211.5M129.7M51.3M145.3M150.2M-900K-90.7M-17.5M-14.7M500K28.2M130M204.8M42.5M159.9M
Pretax Margin %13.94%15.42%13.7%12.04%10.03%13.4%8.31%3.34%9.42%9.82%-0.06%-6.03%-1.21%-0.99%0.04%2.18%9.77%14.9%3.33%12.23%
Income Tax50.3M60.8M48.5M41.9M31.9M44.2M27.6M10.9M29.8M42.9M-9.1M-20.7M-5.5M-2.8M-100K5.4M24.7M42M7.7M30.3M
Effective Tax Rate %21.21%23.58%21.36%21.08%19.93%20.9%21.28%21.25%20.51%28.56%1011.11%22.82%31.43%19.05%-20%19.15%19%20.51%18.12%18.95%
Net Income186.8M198.5M178.7M157.1M128.2M167.9M102.1M40.5M115.5M107.9M8.6M-69.2M-12M-11.6M500K22.7M104.9M163.5M34M128.5M
Net Margin %10.98%11.87%10.78%9.52%8.03%10.64%6.54%2.64%7.49%7.06%0.57%-4.6%-0.83%-0.78%0.04%1.76%7.88%11.89%2.67%9.83%
Net Income Growth %45.71%18.23%75.02%287.9%11%55.61%1087.21%158.53%1062.5%1030.17%1620%-404.85%-111.44%-107.09%-98.53%-82.33%13.16%-0.67%-71.4%11.55%
EPS (Diluted)5.155.474.914.303.504.592.801.123.182.980.24-1.94-0.34-0.330.010.632.904.530.943.52
EPS Growth %47.14%19.17%75.36%283.93%10.06%54.03%1066.67%157.73%1035.29%1003.03%2300%-407.94%-111.72%-107.28%-98.94%-82.1%15.54%2.26%-69.97%16.94%
EPS (Basic)5.265.594.984.383.504.592.801.123.182.980.24-1.94-0.34-0.330.010.632.954.610.953.58
Diluted Shares Outstanding36.3M36.3M36.4M36.4M36.4M36.6M36.5M36.3M36.3M36.2M36.1M35.7M35.6M35.6M36.1M36.1M36.1M36.1M36.3M36.5M